These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38862638)

  • 1. The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria.
    Boyle MJ; Engwerda CR; Jagannathan P
    Nat Rev Immunol; 2024 Jun; ():. PubMed ID: 38862638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.
    Gowda DC; Wu X
    Front Immunol; 2018; 9():3006. PubMed ID: 30619355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Established Immunoregulatory Networks on Vaccine Efficacy and the Development of Immunity to Malaria.
    Montes de Oca M; Good MF; McCarthy JS; Engwerda CR
    J Immunol; 2016 Dec; 197(12):4518-4526. PubMed ID: 27913644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.
    Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF
    BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A guide to investigating immune responses elicited by whole-sporozoite pre-erythrocytic vaccines against malaria.
    Moita D; Nunes-Cabaço H; Mendes AM; Prudêncio M
    FEBS J; 2022 Jun; 289(12):3335-3359. PubMed ID: 33993649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.
    Low LM; Ssemaganda A; Liu XQ; Ho MF; Ozberk V; Fink J; Sundac L; Alcorn K; Morrison A; O'Callaghan K; Gerrard J; Stanisic DI; Good MF
    Infect Immun; 2019 Jan; 87(1):. PubMed ID: 30323025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria.
    Stanisic DI; Ho MF; Nevagi R; Cooper E; Walton M; Islam MT; Hussein WM; Skwarczynski M; Toth I; Good MF
    mBio; 2021 Oct; 12(5):e0265721. PubMed ID: 34663097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets.
    Dooley NL; Chabikwa TG; Pava Z; Loughland JR; Hamelink J; Berry K; Andrew D; Soon MSF; SheelaNair A; Piera KA; William T; Barber BE; Grigg MJ; Engwerda CR; Lopez JA; Anstey NM; Boyle MJ
    Nat Commun; 2023 Nov; 14(1):7387. PubMed ID: 37968278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of CD4
    Kumar R; Loughland JR; Ng SS; Boyle MJ; Engwerda CR
    Immunol Rev; 2020 Jan; 293(1):70-87. PubMed ID: 31674682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Vγ9Vδ2 T Lymphocytes in the Immune Response to
    Howard J; Zaidi I; Loizon S; Mercereau-Puijalon O; Déchanet-Merville J; Mamani-Matsuda M
    Front Immunol; 2018; 9():2760. PubMed ID: 30538708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
    Powell TJ; Tang J; Derome ME; Mitchell RA; Jacobs A; Deng Y; Palath N; Cardenas E; Boyd JG; Nardin E
    Vaccine; 2013 Apr; 31(15):1898-904. PubMed ID: 23481177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
    Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
    BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against
    Reuling IJ; Mendes AM; de Jong GM; Fabra-García A; Nunes-Cabaço H; van Gemert GJ; Graumans W; Coffeng LE; de Vlas SJ; Yang ASP; Lee C; Wu Y; Birkett AJ; Ockenhouse CF; Koelewijn R; van Hellemond JJ; van Genderen PJJ; Sauerwein RW; Prudêncio M
    Sci Transl Med; 2020 May; 12(544):. PubMed ID: 32434846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it.
    Jensen AR; Adams Y; Hviid L
    Immunol Rev; 2020 Jan; 293(1):230-252. PubMed ID: 31562653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phagosomal Acidification Prevents Macrophage Inflammatory Cytokine Production to Malaria, and Dendritic Cells Are the Major Source at the Early Stages of Infection: IMPLICATION FOR MALARIA PROTECTIVE IMMUNITY DEVELOPMENT.
    Wu X; Gowda NM; Gowda DC
    J Biol Chem; 2015 Sep; 290(38):23135-47. PubMed ID: 26240140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional Feeding Reveals Differences in Immune Recognition and Growth of
    Kwon H; Simões ML; Reynolds RA; Dimopoulos G; Smith RC
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33789941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.